Related Experiment Video
Updated: Oct 16, 2025

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
Beyond cuts and scrapes: plasmin in malaria and other vector-borne diseases
Zarna Rajeshkumar Pala1, Medard Ernest1, Brendan Sweeney1
1Laboratory of Malaria and Vector Research, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA.
Abstract:
Plasmodium and other vector-borne pathogens have evolved mechanisms to hijack the mammalian fibrinolytic system to facilitate infection of the human host and the invertebrate vector. Plasmin, the effector protease of fibrinolysis, maintains homeostasis in the blood vasculature by degrading the fibrin that forms blood clots. Plasmin also degrades proteins from extracellular matrices, the complement system, and immunoglobulins. Here, we review some of the mechanisms by which vector-borne pathogens interact with components of the fibrinolytic system and co-opt its functions to facilitate transmission and infection in the host and the vector. Further, we discuss innovative strategies beyond conventional therapeutics that could be developed to target the interaction of vector-borne pathogens with the fibrinolytic proteins and prevent their transmission.
Insights
Vector-borne pathogens like Plasmodium hijack the body's blood clot system (fibrinolysis) to infect hosts and vectors. Targeting these interactions offers novel therapeutic strategies against pathogen transmission.
Area of Science:
- Medical Microbiology
- Parasitology
- Hematology
Background:
- Vector-borne pathogens have evolved sophisticated mechanisms to evade host defenses.
- The mammalian fibrinolytic system, crucial for blood clot breakdown, is a key target for pathogen manipulation.
- Plasmin, the central protease of fibrinolysis, plays a role in both host homeostasis and pathogen infection.
Purpose of the Study:
- To review the mechanisms by which vector-borne pathogens interact with the fibrinolytic system.
- To explore how pathogens co-opt fibrinolytic functions for transmission and infection.
- To discuss novel therapeutic strategies targeting pathogen-fibrinolytic interactions.
Main Methods:
- Literature review of scientific studies on vector-borne pathogens and the fibrinolytic system.
- Analysis of molecular mechanisms underlying pathogen-host interactions.
- Synthesis of current knowledge on therapeutic interventions.
Main Results:
- Vector-borne pathogens, including Plasmodium, utilize components of the fibrinolytic system to facilitate infection.
- Pathogens manipulate plasmin activity to aid in host cell invasion and dissemination.
- These interactions are critical for both human host infection and invertebrate vector transmission.
Conclusions:
- Understanding pathogen exploitation of the fibrinolytic system is crucial for developing new treatments.
- Targeting the interface between pathogens and fibrinolytic proteins presents a promising avenue for novel therapeutics.
- Innovative strategies are needed to disrupt these interactions and prevent disease transmission.
Related Concept Videos
Symbiosis
Overview of Protists
Diversity of Protists II
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Cytoskeletal Linker Proteins - Plakins
Clot Retraction and Fibrinolysis

